EDAP TMS S.A. of Vaulx-en-Velin at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine


4 rue du Dauphiné, 69120 Vaulx-en-Velin
Telephone +33 4 72153150
Fax +33 4 72153151

This company is co-exhibitor of
Business France SA

Hall map

MEDICA 2018 hall map (Hall 17): stand A23

Fairground map

MEDICA 2018 fairground map: Hall 17

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.04  Therapy and physical medicine
  • 01.04.08  Ultrasonic therapy equipment

Ultrasonic therapy equipment

Our products

Product category: Ultrasonic therapy equipment

HIFU for Prostate Cancer

Prostate Cancer is the second most frequently diagnosed cancer. Even if the standard therapies for early-diagnosed prostate cancer (Surgery and Radiotherapy) have shown a high level of oncological efficacy, they are often associated with a high level of morbidity (in particular incontinence and impotence). For more than 2 decades, EDAP TMS has been committed to bringing a non-invasive alternative to prostate cancer patients with optimal efficacy and minimal side effects.

HIFU (High Intensity Focused Ultrasound), jointly developed in the early 1990s by Inserm (French Institute of Medical Research), HCL (Lyon University Hospitals) and EDAP TMS, has been used routinely for more than 20 years throughout the world with more than 40,000 treatments performed on 3 generations of commercial devices: Ablatherm® Maxis (from 1993 to 2005), Ablatherm®Integrated Imaging (since 2005) and Focal One® (since 2013) to treat prostate cancer by creating a precise and irreversible coagulation necrosis of the targeted tissue while preserving the surrounding tissue.

More Less

About us

Company details

EDAP TMS, the world leader in therapeutic ultrasound
Global leader in therapeutic ultrasound and present in the market for more than 35 years, EDAP TMS (NASDAQ: EDAP) develops, manufactures, promotes and distributes minimally-invasive medical devices for urology using ultrasound technology. EDAP TMS is actively operating worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. By constantly investing in Research & Development, partnering with INSERM French public laboratory and internationally renowned medical research institutions, EDAP TMS has developed a strong valuable patent portfolio based on its innovative technologies.

HIFU (High Intensity Focused Ultrasound)
With its complete range of Robotic HIFU devices, Ablatherm® and Focal One®, EDAP TMS is the most innovative company in non-invasive treatment for Prostate Cancer. By combining the latest technologies in imaging and treatment modalities, EDAP TMS recently introduced the Focal One® device as the answer to current requirements for ideal focal therapy of prostate cancer and as a complement to the existing Ablatherm® HIFU.

ESWL (Extracorporeal ShockWave Lithotripsy)
As a pioneer and key player in the field of Extracorporeal ShockWave Lithotripsy, EDAP TMS introduced the first modular lithotripter. The latest generation of shockwave source (Electroconductive Technology) and stone localization (Visio-Track) are utilized exclusively by EDAP TMS in its Sonolith® range of ESWL systems (Sonolith® i-sys and Sonolith® i-move).

Stone Laser
To offer a complete range of minimally invasive solutions covering the full scope of urinary tract stone indications, EDAP TMS has integrated in its portfolio an user-friendly 30W Holmium:YAG Surgical Laser the Laserlith® i-dust.

Laser i-dust® is not available for distribution in France, Morocco, Algeria and Tunisia as EDAP TMS is the exclusive distributor of Lumenis Holmium Lasers in these territories. For more information about Lumenis Holmium lasers, please visit the Lumenis websiteor contact us.

More Less